Literature DB >> 15898744

Probing for integrin alpha v beta3 binding of RGD peptides using fluorescence polarization.

Wei Wang1, Qingping Wu, Marites Pasuelo, John S McMurray, Chun Li.   

Abstract

Integrin alpha(v)beta(3) is an adhesion molecule involved in tumor invasion, angiogenesis, and metastasis. There is substantial interest in developing novel agents that bind to integrin alpha(v)beta(3). Here we report the synthesis and characterization of a fluorescent integrin alpha(v)beta(3) probe and its use in a nonradioactive, simple, sensitive fluorescence polarization (FP) assay to quantify binding to integrin alpha(v)beta(3). For assay validation, the FP assay was compared to a cell adhesion assay. In the two assays, probe binding to integrin alpha(v)beta(3) showed a similar dependence on probe concentration. The FP assay was successfully applied to measure the binding affinity to integrin alpha(v)beta(3) of several cyclic peptides containing the Arg-Gly-Asp (RGD) motif. The FP assay we describe here may be appropriate for high-throughput screening for integrin alpha(v)beta(3)-binding ligands used for anti-integrin therapy or noninvasive imaging of integrin expression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15898744     DOI: 10.1021/bc049763s

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  13 in total

1.  Integrin alphaIIbbeta3:ligand interactions are linked to binding-site remodeling.

Authors:  Roy R Hantgan; Mary C Stahle; John H Connor; David A Horita; Mattia Rocco; Mary A McLane; Sergiy Yakovlev; Leonid Medved
Journal:  Protein Sci       Date:  2006-08       Impact factor: 6.725

2.  In Vitro and In Vivo Efficacy of Self-Assembling RGD Peptide Amphiphiles for Targeted Delivery of Paclitaxel.

Authors:  Poonam Saraf; Xiaoling Li; Lisa Wrischnik; Bhaskara Jasti
Journal:  Pharm Res       Date:  2015-06-11       Impact factor: 4.200

3.  Tumor microenvironment and nanotherapeutics.

Authors:  Meenakshi Upreti; Amar Jyoti; Pallavi Sethi
Journal:  Transl Cancer Res       Date:  2013-08-01       Impact factor: 1.241

4.  Assessing the Flexibility of the Prochlorosin 2.8 Scaffold for Bioengineering Applications.

Authors:  Julian D Hegemann; Silvia C Bobeica; Mark C Walker; Ian R Bothwell; Wilfred A van der Donk
Journal:  ACS Synth Biol       Date:  2019-05-08       Impact factor: 5.110

5.  Effects of photoacoustic imaging and photothermal ablation therapy mediated by targeted hollow gold nanospheres in an orthotopic mouse xenograft model of glioma.

Authors:  Wei Lu; Marites P Melancon; Chiyi Xiong; Qian Huang; Andrew Elliott; Shaoli Song; Rui Zhang; Leo G Flores; Juri G Gelovani; Lihong V Wang; Geng Ku; R Jason Stafford; Chun Li
Journal:  Cancer Res       Date:  2011-08-19       Impact factor: 12.701

Review 6.  Exploiting the tumor microenvironment for theranostic imaging.

Authors:  Ioannis Stasinopoulos; Marie-France Penet; Zhihang Chen; Samata Kakkad; Kristine Glunde; Zaver M Bhujwalla
Journal:  NMR Biomed       Date:  2011-01-28       Impact factor: 4.044

7.  Access to site-specific Fc-cRGD peptide conjugates through streamlined expressed protein ligation.

Authors:  S Frutos; J B Jordan; M M Bio; T W Muir; O R Thiel; M Vila-Perelló
Journal:  Org Biomol Chem       Date:  2016-10-12       Impact factor: 3.876

8.  Initial characterization of a dually radiolabeled peptide for simultaneous monitoring of protein targets and enzymatic activity.

Authors:  Efrem Mebrahtu; Alexander Zheleznyak; Minjun A Hur; Richard Laforest; Suzanne E Lapi
Journal:  Nucl Med Biol       Date:  2012-11-12       Impact factor: 2.408

9.  Tumor uptake of hollow gold nanospheres after intravenous and intra-arterial injection: PET/CT study in a rabbit VX2 liver cancer model.

Authors:  Mei Tian; Wei Lu; Rui Zhang; Chiyi Xiong; Joe Ensor; Javier Nazario; James Jackson; Colette Shaw; Katherine A Dixon; Jennifer Miller; Kenneth Wright; Chun Li; Sanjay Gupta
Journal:  Mol Imaging Biol       Date:  2013-10       Impact factor: 3.488

10.  Application of high-throughput screening to identify a novel alphaIIb-specific small- molecule inhibitor of alphaIIbbeta3-mediated platelet interaction with fibrinogen.

Authors:  Robert Blue; Marta Murcia; Charles Karan; Markéta Jirousková; Barry S Coller
Journal:  Blood       Date:  2007-10-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.